Pharmacovigilance Risk Assessment Committee
GLP-1 medications from Novo Nordisk are being examined in Europe following reports suggest potential suicide risks
SG Tylor
Following reports of two cases of suicidal thoughts and one case of self-harm among users in Iceland, the European Medicines ...
